YSMU Remembers Honorary Doctor and Nobel Laureate Prof. Ada Yonath
Yerevan State Medical University (YSMU) shared a post on LinkedIn:
“Professor Ada Yonath, laureate of the 2009 Nobel Prize in Chemistry and the Israel Prize, YSMU Honorary Doctor and an international model of scientific courage and perseverance, passed away on August 31, 2026.
She was 87.
Yonath, of the Weizmann Institute of Science’s Chemical and Structural Biology Department, pioneered the study of ribosome structure using crystallography and was awarded the Nobel Prize for her research in this field.
Her decades-long scientific journey began with basic research aimed at deciphering the workings of one of nature’s most complex biological machines.
Her research later led to an understanding of how certain antibiotics work, helping pave the way for the development of more advanced antibiotics and the fight against antibiotic-resistant bacteria – one of the most pressing medical challenges of the 21st century.
On April 12-15, 2016, within the framework of the scientific event ‘Nobel Days in Yerevan’ held in Armenia at the initiative of Yerevan State Medical University after Mkhitar Heratsi, Ada Yonath shared her rich experience and knowledge among five Nobel laureates.
This important event, as well as the visit of the famous scientist to YSMU will remain in the historical pages of the annals of the Medical University.”
Stay updated with Hemostasis Today.
-
Oct 26, 2026, 03:43Shazmah Shaikh: How Laser Atherectomy Helps Clear Blocked Arteries
-
Oct 26, 2026, 03:28Priya Prasad: Protecting Donors and Recipients Through Blood Safety
-
Oct 25, 2026, 19:55Giacomo Buso: LIPLEG Provides the Strongest Evidence to Date on Lipedema Treatment
-
Oct 25, 2026, 19:54Nicholas Lee: ASH Program Connects Trainees and Faculty With Mentors for Career Development
-
Oct 25, 2026, 19:53World Thrombosis Day Raises Blood Clot Awareness at Italian Airports
-
Oct 25, 2026, 19:49Tahsim Anwar: A Six-Year Analysis of Adverse Events in Therapeutic Apheresis
-
Oct 25, 2026, 19:37William Wallace: More than 1 in 3 People with Parkinson’s Were Low in B6
-
Oct 25, 2026, 19:36Andrés Felipe Escobar González: Individualized Treatment Strategies for HMB in BDUC
-
Oct 25, 2026, 19:34Christophe Nougier: Returning to Burundi for the WFH-Supported Twinning Project